an increasing trendP =0.598
An increasing trend was shown with respect to the intrahepatic metastasis from 6.7% (1 of 15) in the control group to 20.0% (3 of 15; P =0.598) in the TAE group, and lung metastatic rate from 53.3% (8 of 15) in the control group to 80.0% (12 of 15; P =0.245) in the TAE group.